Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies
2014; Springer Science+Business Media; Volume: 94; Issue: 1 Linguagem: Inglês
10.1007/s00277-014-2177-y
ISSN1432-0584
AutoresMargriet Oosterveld, Stefan Suciu, Petra Muus, Ulrich Germing, Michel Delforge, A Belhabri, Carlo Aul, Dominik Selleslag, Augustin Ferrant, Jean‐Pierre Marie, Sergio Amadori, U. Jehn, Franco Mandelli, U Hess, Eva Hellström‐Lindberg, Songuel Cakmak-Wollgast, Marco Vignetti, Boris Labar, Roel Willemze, Théo de Witte,
Tópico(s)Hematological disorders and diagnostics
Referência(s)